NEW Podcast Series 
MIDI has launched a brand new podcast series, NextGen CAR T-cell Therapy; Democratization via Advanced Point-of-Care Production and Applications.

In this podcast series on CAR T-cell Therapy, MIDI’s CEO and Co-Founder, Chris Montalbano, discusses his insight into this exciting and rapidly evolving field in cancer treatment.  

The first FDA-approved CAR T-cell biopharmaceutical drug was introduced in 2017. Currently, there are approximately 10 approved drugs, and the number in development and FDA approval pipeline is growing exponentially.  This therapy is unique because it specifically targets cancer cells while sparing healthy cells, in contrast to other treatment methods that can kill both. The precision of this approach has generated much excitement within the medical community, as it has the potential to revolutionize cancer treatment. 

In this PodCast series, we will be discussing methods that can help mitigate the hurdles of time and cost by allowing the production process to scale in high volume, thus dropping cost per therapy, increasing production turn-around time and making the therapy accessible to a much larger population of patients.  It’s a POC (Point of Care) approach, where the biopharma product is produced at or near the patient treatment site. This will provide for true Democratization.

Downloadable MIDI White Paper: Paradigm Shift in Medical Device Development – The INNOVATION ROADMAP™

A new version of MIDI’s White Paper, Paradigm Shift in Medical Device Development, is now available.  We invite you to journey with us on the Innovation Roadmap™: Embracing Regulatory Controls to Foster Innovation. 

MIDI’s Innovation Roadmap™ is an approach designed to respond to any challenge that may arise when developing medical devices. This overview addresses but a small portion of the wide range of hurdles facing developers. Yet, it will also demonstrate how regulatory controls can be leveraged in the development process to produce a device that is truly innovative. This MIDI process results in a device which will be reliable, safe, and effective for its users while infusing competitive differentiation.

You can download your copy of the latest MIDI White Paper here, Paradigm Shift in Medical Device Development: The INNOVATION ROADMAP™